EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden: insights from SWENOTECA

Anna Thor iD, Anna Grenabo Bergdahl iD, Armin Abniki, Axel Gerdtsson iD, Ingrid Glimelius iD, Martin Hellström, Anna K Jansson iD, Berglind Johannsdottir iD, Torgrim Tandstad iD, Gabriella Cohn-Cedermark iD, Anders Kjellman iD, Per-Olof Lundgren iD

Scandinavian Journal of Urology · 13.04.2026 · 61 · 112-120

DOI: 10.2340/sju.v61.45743 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Scandinavian Journal of Urology, online erschienen am 13.04.2026. Verfasst von Anna Thor und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institute, Stockholm, Sweden; Department of Urology, Pel…. Hauptthemen laut MEDLINE: Testicular Neoplasms, Lymph Node Excision, Postoperative Complications, Neoplasms, Germ Cell and Embryonal. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Retroperitoneal lymph node dissection (RPLND) for testicular germ cell cancer is a complex procedure associated with postoperative complications and long-term morbidity, best performed by experienced surgeons at high-volume centers. This study evaluates surgical outcomes of RPLND in a centralized population-based cohort.

Methods

This is a retrospective analysis of a prospective multicenter cohort of all RPLNDs in Sweden between 2018 and 2022. 217 patients (175 nonseminomas and 42 seminomas) underwent unilateral or bilateral primary RPLND or post-chemotherapy RPLND. Primary outcomes were complications, loss of ejaculation, and histopathology.

Results

Intraoperative complications occurred in 8% of unilateral and 0% of bilateral templates in primary RPLND, and in 0 and 8% in post-chemotherapy RPLND, most commonly renal injury. Postoperative complications rate was significantly higher with bilateral templates in post-chemotherapy RPLND (49% vs 18%, p < 0.01). Clavien-Dindo ≥ IIIb complications occurred in 2 (primary) and 3% (post-chemotherapy), respectively. Loss of ejaculation was numerically more common after bilateral templates (primary: 60% vs 31%, p = 0.07; post-chemotherapy: 53% vs 38%, p = 0.09). Viable cancer was found in 95% of seminomas and 52% of nonseminomas for primary RPLND and in nonseminoma post-chemotherapy RPLND, 11% viable cancer, 50% teratoma, and 39% benign nodes. Robotic surgery did not increase complications or loss of ejaculation.

Conclusions

RPLND demonstrated low complication rates and rare serious events. Bilateral templates were associated with increased loss of ejaculation. Robotic surgery was safe, and prior chemotherapy did not preclude laparoscopy. Post-chemotherapy RPLND showed more teratoma and viable cancer, and fewer benign findings than previously reported.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Testicular NeoplasmsLymph Node ExcisionPostoperative ComplicationsNeoplasms, Germ Cell and EmbryonalSeminomaMaleHumansSwedenRetrospective StudiesRetroperitoneal SpaceAdultTreatment OutcomeIntraoperative ComplicationsEjaculationMiddle Aged

Autor:innen und Institutionen

  • Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institute, Stockholm, Sweden; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden. anna.th…
  • Department of Urology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Urology, Gothenburg, Sweden.
  • Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institute, Stockholm, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden; Institution of Translational Me…
  • Department of Immunology, Genetics & Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, Sweden.
  • Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden.

ORCID-Profile: Anna Thor, Anna Grenabo Bergdahl, Axel Gerdtsson, Ingrid Glimelius, Anna K Jansson, Berglind Johannsdottir, Torgrim Tandstad, Gabriella Cohn-Cedermark, Anders Kjellman, Per-Olof Lundgren

Zitieren

APA

Thor, A., Grenabo Bergdahl, A., Abniki, A., Gerdtsson, A., Glimelius, I., Hellström, M., Jansson, A. K., Johannsdottir, B., Tandstad, T., Cohn-Cedermark, G., Kjellman, A., & Lundgren, P. O. (2026). Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden: insights from SWENOTECA. Scandinavian Journal of Urology, 61, 112-120. https://doi.org/10.2340/sju.v61.45743

Vancouver

Thor A, Grenabo Bergdahl A, Abniki A, Gerdtsson A, Glimelius I, Hellström M, et al. Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden: insights from SWENOTECA. Scandinavian Journal of Urology. 2026;61:112-120. doi:10.2340/sju.v61.45743

BibTeX
@article{Thor2026,
  author = {Thor, Anna and Grenabo Bergdahl, Anna and Abniki, Armin and Gerdtsson, Axel and Glimelius, Ingrid and Hellström, Martin and Jansson, Anna K and Johannsdottir, Berglind and Tandstad, Torgrim and Cohn-Cedermark, Gabriella and Kjellman, Anders and Lundgren, Per-Olof},
  title = {Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden: insights from SWENOTECA},
  journal = {Scandinavian Journal of Urology},
  year = {2026},
  volume = {61},
  pages = {112--120},
  doi = {10.2340/sju.v61.45743}
}
Kostenlos starten →